Structure of the catalytically active APOBEC3G bound to a DNA oligonucleotide inhibitor reveals tetrahedral geometry of the transition state
A. Maiti, A. Hedger, W. Myint, V. Balachandran, J. Watts, C. A. Schiffer, H. Matsuo
Abstract
APOBEC3 proteins (A3s) are enzymes that catalyze deamination of cytidine to uridine in single-stranded DNA (ssDNA) substrates, thus playing a key role in innate antiviral immunity. However, APOBEC3 family has also been linked to many mutational signatures in cancer cells, which has led to intense interest to develop inhibitors of A3s catalytic activity as therapeutics as well as tools to study A3s biochemistry, structure and cellular function. Recent studies have shown that ssDNA containing 2'-deoxy-zebularine (dZ-ssDNA) is an inhibitor of A3s such as A3A, A3B and A3G, although atomic determinants of this activity remained unknown. To fill this knowledge gap, we determined a 1.5 [A] resolution structure of a dZ-ssDNA inhibitor bound to active A3G. The crystal structure revealed that the activated dZ/H2O mimics the transition state by coordinating the active site Zn2+ and engaging in additional stabilizing interactions, such as the one with the catalytic residues E259. Therefore, this structure allowed us to capture the first snapshot of the A3s transition state, and suggests that developing transition-state mimicking inhibitors may provide a new opportunity to design more targeted molecules for A3s in the future.
02 /Specification & Classification
Click any tag to browse matching papers- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Active site plasticity and possible modes of chemical inhibition of the human DNA deaminase APOBEC3B
- Structural analysis of the active site and DNA binding of human cytidine deaminase APOBEC3B
S. Hou, T. V. Silvas, … C. A. Schiffer·bioRxiv·Apr 18, 2018
- Structure-guided inhibition of the cancer DNA-mutating enzyme APOBEC3A
S. Harjes, H. M. Kurup, … G. B. Jameson·bioRxiv·Feb 17, 2023
- Next generation APOBEC3 inhibitors: Optimally designed for potency and nuclease stability
Adam K. Hedger, Wazo Myint, … Celia A. Schiffer·Nucleic Acids ResearchPeer-reviewed·Mar 16, 2025
- Substrate sequence selectivity of APOBEC3A implicates intra-DNA interactions
T. V. Silvas, S. Hou, … C. A. Schiffer·bioRxiv·Aug 17, 2017
- Computational Discovery of an Allosteric Pocket on APOBEC3B and the Impact of Metal Contamination on Inhibitor Validation
Mackenzie K. Wyllie, Katherine F. M. Jones, … Daniel A. Harki·bioRxiv·Apr 25, 2024